Related Experiment Videos
Factors influencing early renal function in cadaver kidney transplants. A case-control study
1Toronto General Hospital, Ontario, Canada.
Transplantation
|January 1, 1988
Summary
Kidney transplant outcomes improve by reducing cold ischemia and anastomosis times. Avoiding rejection through antilymphocyte globulin (ALG) prophylaxis is crucial for preventing never-function (NF) transplants, especially in patients with prior transplant failure.
Area of Science:
- Nephrology
- Transplant Surgery
- Immunology
Background:
- Cadaver kidney transplants can experience delayed or never-achieving function, impacting patient outcomes.
- Understanding risk factors for these suboptimal graft outcomes is essential for improving transplant success rates.
Purpose of the Study:
- To identify risk factors associated with kidney transplants that never function (NF) or have delayed function (DF).
- To compare NF and DF outcomes with early graft function (EF) using multivariate analysis.
Main Methods:
- A multicenter study comparing 69 NF, 69 DF, and 69 EF cadaver kidney transplant recipients.
- Unconditional logistic regression was used to model risk factors.
- Analysis accounted for factors including previous transplant history, immunosuppression, and surgical/ischemic times.
Main Results:
- Key risk factors for NF transplants included previous failed transplant, no antilymphocyte globulin (ALG) prophylaxis, longer anastomosis time, and lower donor blood pressure.
- Severe rejection was identified as the primary cause of NF outcomes when technical failures were excluded.
- Risk factors for DF included longer anastomosis and cold ischemia times, no ALG prophylaxis, longer duration of end-stage renal disease (ESRD), and male sex.
Conclusions:
- Both ischemic and immunologic factors contribute to delayed and never-function outcomes in kidney transplantation.
- Reducing cold ischemia and anastomosis times, alongside utilizing ALG prophylaxis, can mitigate NF and DF outcomes.
- Special attention should be given to recipients with a history of prior transplant failure.